The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Large Volume Parenteral (LVP) Market Outlook 2024
Synopsis
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
The global Large Volume Parenteral (LVP) market was valued at US$ 9497 million in 2020 and is expected to reach US$ 13400 million by the end of 2027, growing at a CAGR of 4.1% during 2021-2027.
This report focuses on Large Volume Parenteral (LVP) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Large Volume Parenteral (LVP) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Large Volume Parenteral (LVP) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
The global Large Volume Parenteral (LVP) market was valued at US$ 9497 million in 2020 and is expected to reach US$ 13400 million by the end of 2027, growing at a CAGR of 4.1% during 2021-2027.
This report focuses on Large Volume Parenteral (LVP) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Large Volume Parenteral (LVP) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Large Volume Parenteral (LVP) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
Index1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application: (2021-2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2016-2027
1.4.2 Global Large Volume Parenteral (LVP) Sales 2016-2027
1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue
2.5.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenteral (LVP) Sales by Country
3.3.2 North America Large Volume Parenteral (LVP) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.2 Europe Large Volume Parenteral (LVP) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenteral (LVP) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Corporation Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Pharma
6.2.1 Kelun Pharma Corporation Information
6.2.2 Kelun Pharma Description and Business Overview
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Fresenius
6.4.1 Fresenius Corporation Information
6.4.2 Fresenius Description and Business Overview
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.4.5 Fresenius Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Corporation Information
6.6.2 Pfizer (Hospira) Description and Business Overview
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
6.6.5 Pfizer (Hospira) Recent Developments/Updates
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Corporation Information
6.6.2 Ostuka Pharmaceutical Description and Business Overview
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.7.5 Ostuka Pharmaceutical Recent Developments/Updates
6.8 CR Double-Crane
6.8.1 CR Double-Crane Corporation Information
6.8.2 CR Double-Crane Description and Business Overview
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
6.8.5 CR Double-Crane Recent Developments/Updates
6.9 Pisa
6.9.1 Pisa Corporation Information
6.9.2 Pisa Description and Business Overview
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Pisa Recent Developments/Updates
6.10 Huaren
6.10.1 Huaren Corporation Information
6.10.2 Huaren Description and Business Overview
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
6.10.5 Huaren Recent Developments/Updates
6.11 Patheon
6.11.1 Patheon Corporation Information
6.11.2 Patheon Large Volume Parenteral (LVP) Description and Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments/Updates
6.12 Beximco Pharma
6.12.1 Beximco Pharma Corporation Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Description and Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments/Updates
6.13 Albert David
6.13.1 Albert David Corporation Information
6.13.2 Albert David Large Volume Parenteral (LVP) Description and Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments/Updates
6.14 PSI Ltd
6.14.1 PSI Ltd Corporation Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Description and Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments/Updates
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Corporation Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description and Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments/Updates
6.16 BAG Healthcare
6.16.1 BAG Healthcare Corporation Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Description and Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Corporation Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenteral (LVP) Distributors List
8.3 Large Volume Parenteral (LVP) Customers
9 Large Volume Parenteral (LVP) Market Dynamics
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Growth Drivers
9.3 Large Volume Parenteral (LVP) Market Challenges
9.4 Large Volume Parenteral (LVP) Market Restraints
10 Global Market Forecast
10.1 Large Volume Parenteral (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2022-2027)
10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2022-2027)
10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Large Volume Parenteral (LVP) Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Large Volume Parenteral (LVP) Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Large Volume Parenteral (LVP) Covered in This Study
Table 5. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites and Area Served
Table 11. Manufacturers Large Volume Parenteral (LVP) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 16. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 17. Global Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 19. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 20. North America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 22. Europe Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 23. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 24. Europe Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 32. Latin America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2016-2021)
Table 38. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2016-2021)
Table 39. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 40. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Large Volume Parenteral (LVP) Revenue Share by Type (2016-2021)
Table 42. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2016-2021)
Table 43. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2016-2021)
Table 44. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 45. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Large Volume Parenteral (LVP) Revenue Share by Application (2016-2021)
Table 47. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2016-2021)
Table 48. Baxter Healthcare Corporation Information
Table 49. Baxter Healthcare Description and Business Overview
Table 50. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 51. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 52. Baxter Healthcare Recent Developments/Updates
Table 53. Kelun Pharma Corporation Information
Table 54. Kelun Pharma Description and Business Overview
Table 55. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 56. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 57. Kelun Pharma Recent Developments/Updates
Table 58. B. Braun Corporation Information
Table 59. B. Braun Description and Business Overview
Table 60. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 61. B. Braun Large Volume Parenteral (LVP) Product
Table 62. B. Braun Recent Developments/Updates
Table 63. Fresenius Corporation Information
Table 64. Fresenius Description and Business Overview
Table 65. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 66. Fresenius Large Volume Parenteral (LVP) Product
Table 67. Fresenius Recent Developments/Updates
Table 68. Teva Pharmaceutical Industries Corporation Information
Table 69. Teva Pharmaceutical Industries Description and Business Overview
Table 70. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 71. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 72. Teva Pharmaceutical Industries Recent Developments/Updates
Table 73. Pfizer (Hospira) Corporation Information
Table 74. Pfizer (Hospira) Description and Business Overview
Table 75. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 76. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 77. Pfizer (Hospira) Recent Developments/Updates
Table 78. Ostuka Pharmaceutical Corporation Information
Table 79. Ostuka Pharmaceutical Description and Business Overview
Table 80. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 81. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 82. Ostuka Pharmaceutical Recent Developments/Updates
Table 83. CR Double-Crane Corporation Information
Table 84. CR Double-Crane Description and Business Overview
Table 85. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 86. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 87. CR Double-Crane Recent Developments/Updates
Table 88. Pisa Corporation Information
Table 89. Pisa Description and Business Overview
Table 90. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 91. Pisa Large Volume Parenteral (LVP) Product
Table 92. Pisa Recent Developments/Updates
Table 93. Huaren Corporation Information
Table 94. Huaren Description and Business Overview
Table 95. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 96. Huaren Large Volume Parenteral (LVP) Product
Table 97. Huaren Recent Developments/Updates
Table 98. Patheon Corporation Information
Table 99. Patheon Description and Business Overview
Table 100. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 101. Patheon Large Volume Parenteral (LVP) Product
Table 102. Patheon Recent Developments/Updates
Table 103. Beximco Pharma Corporation Information
Table 104. Beximco Pharma Description and Business Overview
Table 105. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 106. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 107. Beximco Pharma Recent Developments/Updates
Table 108. Albert David Corporation Information
Table 109. Albert David Description and Business Overview
Table 110. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 111. Albert David Large Volume Parenteral (LVP) Product
Table 112. Albert David Recent Developments/Updates
Table 113. PSI Ltd Corporation Information
Table 114. PSI Ltd Description and Business Overview
Table 115. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 116. PSI Ltd Large Volume Parenteral (LVP) Product
Table 117. PSI Ltd Recent Developments/Updates
Table 118. Ozon Pharmaceuticals Corporation Information
Table 119. Ozon Pharmaceuticals Description and Business Overview
Table 120. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 121. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
Table 122. Ozon Pharmaceuticals Recent Developments/Updates
Table 123. BAG Healthcare Corporation Information
Table 124. BAG Healthcare Description and Business Overview
Table 125. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 126. BAG Healthcare Large Volume Parenteral (LVP) Product
Table 127. BAG Healthcare Recent Developments/Updates
Table 128. BML Parenteral Drugs Corporation Information
Table 129. BML Parenteral Drugs Description and Business Overview
Table 130. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (US$/K Units) and Gross Margin (2016-2021)
Table 131. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
Table 132. BML Parenteral Drugs Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Large Volume Parenteral (LVP) Distributors List
Table 136. Large Volume Parenteral (LVP) Customers List
Table 137. Large Volume Parenteral (LVP) Market Trends
Table 138. Large Volume Parenteral (LVP) Growth Drivers
Table 139. Large Volume Parenteral (LVP) Market Challenges
Table 140. Large Volume Parenteral (LVP) Market Restraints
Table 141. Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027) & (M Units)
Table 142. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Type (2022-2027)
Table 143. Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Type (2022-2027)
Table 145. Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027) & (M Units)
Table 146. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Application (2022-2027)
Table 147. Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Application (2022-2027)
Table 149. Global Large Volume Parenteral (LVP) Sales Forecast by Region (2022-2027) & (M Units)
Table 150. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2022-2027)
Table 151. Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 152. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Region (2022-2027)
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Large Volume Parenteral (LVP)
Figure 2. Global Large Volume Parenteral (LVP) Market Share by Type in 2020 & 2027
Figure 3. Soft Bag LVP Product Picture
Figure 4. Plastic Bottle LVP Product Picture
Figure 5. Glass Bottle LVP Product Picture
Figure 6. Global Large Volume Parenteral (LVP) Market Share by Application in 2020 & 2027
Figure 7. Basic Infusion
Figure 8. Therapeutic Infusion
Figure 9. Nutritious Infusion
Figure 10. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Large Volume Parenteral (LVP) Market Size 2016-2027 (US$ Million)
Figure 12. Global Large Volume Parenteral (LVP) Sales 2016-2027 (M Units)
Figure 13. Global Large Volume Parenteral (LVP) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2020
Figure 15. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Large Volume Parenteral (LVP) Players: Market Share by Revenue in 2020
Figure 17. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Figure 19. Global Large Volume Parenteral (LVP) Sales Market Share by Region in 2020
Figure 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
Figure 21. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in 2020
Figure 22. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Large Volume Parenteral (LVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Large Volume Parenteral (LVP) by Type (2016-2021)
Figure 45. Sales Market Share of Large Volume Parenteral (LVP) by Application (2016-2021)
Figure 46. Sales Market Share of Large Volume Parenteral (LVP) by Application in 2020
Figure 47. Revenue Share of Large Volume Parenteral (LVP) by Application (2016-2021)
Figure 48. Revenue Share of Large Volume Parenteral (LVP) by Application in 2020
Figure 49. Manufacturing Cost Structure of Large Volume Parenteral (LVP)
Figure 50. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 51. Large Volume Parenteral (LVP) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
